Nasal cavity protective agent

A protective agent, nasal technology, applied in the direction of anti-inflammatory agents, non-central pain relievers, plant raw materials, etc.

Inactive Publication Date: 2013-05-08
章迅
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, because the mechanism of allergic respiratory diseases such as allergic rhinitis is difficult to explain, treatment and prevention are still medical problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] The eucalyptus oil, tea tree oil, peppermint oil and lavender oil used in the nasal cavity protector of the present invention are obtained by distillation from the stems, leaves and flowers of the plants, and the Enteromorpha oil is obtained by pressing the marine plant Enteromorpha and edible vegetable oil. By controlling the amount of various ingredients added during the compounding process, it contains terpinenol-4: 3~30%; terpinene: 2~20%.

[0022] The above-mentioned embodiments have been verified by test subjects, and have a clear relief effect on the discomfort caused by various nasal cavity diseases including allergic diseases, and have a protective effect on the nasal cavity mucous membrane.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an external nasal cavity protective agent used for allergic rhinitis, acute rhinitis and other nasal cavity and respiratory mucosa inflammations. The using method of the protective agent comprises the step of daubing the protective agent on the front section of the nasal cavity. The nasal cavity protective agent comprises the following components in percentage by weight: 2-30 percent of eucalyptus oil, 2-30 percent of tea tree oil, 2-30 percent of peppermint oil, 2-30 percent of lavender oil, 1-2 percent of enteromorpha oil and 40-90 percent of edible plant oil. The external nasal cavity protective agent has the functions that 1, the protective agent has the antihistamine function, has high effect on allergic rhinitis, acute rhinitis and the like and is fast in effect and durable in effect; 2, the nasal cavity and respiratory mucosa can be activated, and the capacity of the respiratory mucosa for resisting microbial infection is improved; 3, the nasal cavity biological environment is improved, the other symptoms of the nasal cavity are relieved, and the mucosa wound healing is promoted; 4, the protective agent has the functions of inhibiting bacteria, moulds, mycoplasma, viruses and other microbes; 5, the protective agent has the protective functions of delaying water evaporation and isolating sensitizing and pathogenic factors on the nasal cavity mucosa; 6, the protective agent is highly safe to human mucosa tissue and has a health-care function; and 7, the protective agent is convenient to use and high in economical efficiency.

Description

technical field [0001] The invention relates to a nasal cavity protector for human nasal cavity inflammation (especially for allergic rhinitis). Background technique [0002] The nasal cavity is the primary barrier to upper airway health. Nasal mucosa is very prone to pathological changes due to various external environmental factors and the human body's own pathological stimulation. All kinds of nasal cavity inflammation, especially allergic rhinitis is the most prone and common nasal cavity disease, which not only directly causes pain to patients, but also about 40% of allergic rhinitis will transform into allergic asthma, etc., causing serious harm to human health. greater harm. At present, because the mechanism of allergic respiratory diseases such as allergic rhinitis is difficult to explain, treatment and prevention are still medical problems. [0003] The invention is composed of medicinal and edible plant components, and has good affinity to human body. Among the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/61A61P11/02A61P37/08A61P29/00
Inventor 章迅
Owner 章迅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products